PB2171: POTENTIAL ROLE OF FACTOR XII POLYMORPHISM IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

por Efremova, Elizaveta, Kapustin, Sergey, Nemscveridze, Nadezhda, Pirkhalo, Anna, Mileeva, Ekaterina, Silina, Natalia, Korsakova, Natalia, Matvienko, Olesia, Papayan, Ludmila, Voloshin, Sergey
Publicado 2023

Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience

por Chitanava, Tamara, Matvienko, Iuliia, Shuvaev, Vasily, Voloshin, Sergey, Martynkevich, Irina, Vlasova, Yulia, Efremova, Elizaveta, Mileeva, Ekaterina, Pirkhalo, Anna, Makarova, Taiana, Vlasik, Roman, Karyagina, Elena, Il`ina, Natalia, Medvedeva, Nadezhda, Dorofeeva, Natalia, Shneider, Tatiana, Siordiya, Nadia, Kulemina, Olga, Sbityakova, Evgenia, Lazorko, Natalia, Alexeeva, Julia, Motorin, Dmitrii, Morozova, Elena, Lomaia, Elza
Publicado 2023